Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells |
| |
Authors: | Elena Riboldi Roberta Daniele Marco A. Cassatella Silvano Sozzani Daniela Bosisio |
| |
Affiliation: | aDepartment of Biomedical Sciences and Biotechnology, Unit of General Pathology and Immunology, University of Brescia, Viale Europa 11, 25123 Brescia, Italy;bDepartment of Pathology, Section of General Pathology, University of Verona, Verona, Italy |
| |
Abstract: | Plasmacytoid dendritic cells (PDC) are a functionally distinct lineage of dendritic cells characterized by the release of large amounts of type I interferon (IFN I). IFN I release is efficiently triggered by viral infection and modulates several aspects of immune reactions including the activation of cytotoxic mechanisms finalized to the elimination of infected cells. In this study, we report that TLR7 and TLR9 ligands can induce the secretion of biologically active TNF-related apoptosis-inducing ligand (TRAIL) by PDC. Accordingly, PDC supernatant is endowed with TRAIL-mediated cytotoxic activity when tested on a TRAIL-sensitive Jurkat cell line. TRAIL production is only partially dependent on the autocrine production of IFN I as documented by the use of a blocking anti-IFNRA antibody and the stimulation with exogenous IFN I. Importantly, both TRAIL secretion and cytotoxic activity of PDC supernatants are completely abolished by BDCA2 ligation. These results provide further insights into the biological role of BDCA-2 and document a negative regulatory pathway of PDC cytotoxic activity that may be relevant in pathological situations such as tumors and autoimmune diseases. |
| |
Keywords: | BDCA-2 Plasmacytoid dendritic cells TRAIL Cytotoxicity |
本文献已被 ScienceDirect 等数据库收录! |
|